QT
CELG

Quantamental Technologies’s Celgene Corp CELG Stock Holding History

Quantamental Technologies’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14,530
Closed -$1.34M – 2008
2019
Q2 		$1.34M Buy
14,530
+13,146
+950% +$1.25M 0.49% 10
2019
Q1 		$131K Sell
1,384
-3,596
-72% -$314K 0.06% 520
2018
Q4 		$319K Buy
+4,980
New +$368K 0.19% 127

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Quantamental Technologies's CELG Position: Q3 2019 in Review

Quantamental Technologies sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 14,530 shares — an estimated $1.34M sold.

Quantamental Technologies first reported a position in CELG in Q4 2018 and held it in 3 quarters. The position peaked at $1.34M in Q2 2019. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Quantamental Technologies reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Quantamental Technologies sold 14,530 Celgene Corp shares in Q3 2019, an estimated $1.34M.
  • Quantamental Technologies first reported a position in Celgene Corp in Q4 2018 and held it in 3 quarters.
  • Quantamental Technologies's Celgene Corp position peaked at $1.34M in Q2 2019.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Quantamental Technologies's 13F filing for Q3 2019, filed 8 Nov 2019.